Shahin Moledina

8.7k total citations
36 papers, 713 citations indexed

About

Shahin Moledina is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Shahin Moledina has authored 36 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 22 papers in Cardiology and Cardiovascular Medicine and 20 papers in Epidemiology. Recurrent topics in Shahin Moledina's work include Pulmonary Hypertension Research and Treatments (30 papers), Congenital Heart Disease Studies (20 papers) and Cardiovascular Function and Risk Factors (8 papers). Shahin Moledina is often cited by papers focused on Pulmonary Hypertension Research and Treatments (30 papers), Congenital Heart Disease Studies (20 papers) and Cardiovascular Function and Risk Factors (8 papers). Shahin Moledina collaborates with scholars based in United Kingdom, United States and France. Shahin Moledina's co-authors include Ingram Schulze‐Neick, Sheila G. Haworth, Alison A. Hislop, Vivek Muthurangu, Andrew M. Taylor, Jennifer A. Steeden, Bejal Pandya, Daniel Knight, Cátherine M. Owens and Michael A. Quail and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shahin Moledina

33 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahin Moledina United Kingdom 13 598 435 279 135 78 36 713
Ivo R. Henkens Netherlands 11 435 0.7× 469 1.1× 121 0.4× 91 0.7× 30 0.4× 13 590
Mark‐Jan Ploegstra Netherlands 14 511 0.9× 306 0.7× 247 0.9× 148 1.1× 62 0.8× 24 563
Janette T. Reyes Canada 7 345 0.6× 247 0.6× 148 0.5× 62 0.5× 61 0.8× 9 395
Onno A. Spruijt Netherlands 11 376 0.6× 337 0.8× 107 0.4× 50 0.4× 20 0.3× 20 459
John Papagiannis Greece 18 256 0.4× 923 2.1× 462 1.7× 363 2.7× 47 0.6× 61 1.2k
Roald J. Roeleveld Netherlands 5 432 0.7× 393 0.9× 101 0.4× 65 0.5× 29 0.4× 6 504
Steven D. Colan United States 9 382 0.6× 411 0.9× 534 1.9× 401 3.0× 25 0.3× 12 826
Milena Cecere Italy 10 205 0.3× 385 0.9× 53 0.2× 58 0.4× 28 0.4× 15 509
J Winkler Germany 5 493 0.8× 306 0.7× 48 0.2× 119 0.9× 50 0.6× 7 540
Kristina Kudelko United States 10 359 0.6× 274 0.6× 39 0.1× 90 0.7× 51 0.7× 18 461

Countries citing papers authored by Shahin Moledina

Since Specialization
Citations

This map shows the geographic impact of Shahin Moledina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahin Moledina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahin Moledina more than expected).

Fields of papers citing papers by Shahin Moledina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahin Moledina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahin Moledina. The network helps show where Shahin Moledina may publish in the future.

Co-authorship network of co-authors of Shahin Moledina

This figure shows the co-authorship network connecting the top 25 collaborators of Shahin Moledina. A scholar is included among the top collaborators of Shahin Moledina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahin Moledina. Shahin Moledina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newman, Joseph, Hakim Ghani, G. Fischer, et al.. (2025). The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients. ERJ Open Research. 11(6). 297–2025.
2.
3.
4.
Lammers, Astrid E., Jan Marek, Gerhard‐Paul Diller, Sheila G. Haworth, & Shahin Moledina. (2023). Prognostic Value of Transthoracic Echocardiography in Children With Pulmonary Arterial Hypertension. Journal of the American Heart Association. 12(6). e023118–e023118. 4 indexed citations
5.
Constantine, Andrew, Konstantinos Dimopoulos, Sheila G. Haworth, Vivek Muthurangu, & Shahin Moledina. (2022). Twenty-Year Experience and Outcomes in a National Pediatric Pulmonary Hypertension Service. American Journal of Respiratory and Critical Care Medicine. 206(6). 758–766. 10 indexed citations
6.
7.
Constantine, Andrew, Konstantinos Dimopoulos, Robert Tulloh, et al.. (2021). Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom. Journal of the American Heart Association. 11(1). e023035–e023035. 11 indexed citations
8.
Jansen, Katrijn, Andrew Constantine, Robin Condliffe, et al.. (2021). Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation. Expert Review of Cardiovascular Therapy. 19(9). 837–855. 4 indexed citations
9.
Constantine, Andrew, et al.. (2020). PAH-CHD: transition to adulthood. SHILAP Revista de lepidopterología. 4(S1). 1 indexed citations
10.
Tran‐Lundmark, Karin, et al.. (2020). Pulmonary Vasodilator Therapy in Children with Single Ventricle Physiology: Effects on Saturation and Pulmonary Arterial Pressure. Pediatric Cardiology. 41(8). 1651–1659. 9 indexed citations
11.
12.
Shen, Lei, Xavier Norel, Shahin Moledina, et al.. (2019). Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension. Biochemical Pharmacology. 166. 242–252. 6 indexed citations
13.
Zijlstra, Willemijn M. H., D. Dunbar Ivy, Damien Bonnet, et al.. (2017). Pulmonary arterial hypertension in children after neonatal arterial switch operation. Heart. 103(16). 1244–1249. 15 indexed citations
14.
Wardle, Andrew J, Athanasios Charalampopoulos, Ingram Schulze‐Neick, et al.. (2015). Feasibility and safety of cardiopulmonary exercise testing in children with pulmonary hypertension. Cardiology in the Young. 26(6). 1144–1150. 11 indexed citations
15.
Knight, Daniel, et al.. (2015). Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study. Journal of Cardiovascular Magnetic Resonance. 17(1). 116–116. 38 indexed citations
16.
Pandya, Bejal, Michael A. Quail, Jennifer A. Steeden, et al.. (2014). Real-Time Magnetic Resonance Assessment of Septal Curvature Accurately Tracks Acute Hemodynamic Changes in Pediatric Pulmonary Hypertension. Circulation Cardiovascular Imaging. 7(4). 706–713. 31 indexed citations
17.
Hislop, Alison A., et al.. (2010). Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children. European Respiratory Journal. 38(1). 70–77. 57 indexed citations
18.
Moledina, Shahin, et al.. (2010). Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart. 96(17). 1401–1406. 152 indexed citations
19.
Moledina, Shahin, et al.. (2009). Abstract 5931: Fractal Dimension: A Novel Method of Quantifying Vascular Structural Changes in Pulmonary Hypertension. Circulation. 120. 2 indexed citations
20.
Connor, Philip, Paul Veys, Persis Amrolia, et al.. (2008). PULMONARY HYPERTENSION IN CHILDREN WITH EVANS SYNDROME. Pediatric Hematology and Oncology. 25(2). 93–98. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivo R. Henkens Breakdown of academic impact, for papers by Mark‐Jan Ploegstra Breakdown of academic impact, for papers by Janette T. Reyes Breakdown of academic impact, for papers by Onno A. Spruijt Breakdown of academic impact, for papers by John Papagiannis Breakdown of academic impact, for papers by Roald J. Roeleveld Breakdown of academic impact, for papers by Steven D. Colan Breakdown of academic impact, for papers by Milena Cecere Breakdown of academic impact, for papers by J Winkler Breakdown of academic impact, for papers by Kristina Kudelko
Rankless by CCL
2026